Streptococcus pyogenes isolates causing severe infections in Norway in 2006 to 2007: Emm types, multilocus sequence types, and superantigen profiles

Journal of Clinical Microbiology

Volumn 48, Issue 3, 2010, Pages 842-851

  Meisal, Roger ^a,b   Andreasson, Ida K G ^a   Høiby, E Arne ^a   Aaberge, Ingeborg S ^a   Michaelsen, Terje E ^a,b   Caugant, Dominique A ^a,b  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DALFOPRISTIN PLUS QUINUPRISTIN; MACROLIDE; OFLOXACIN; PENICILLIN G; SUPERANTIGEN; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; FEMALE; GENETIC TRAIT; GROUP A STREPTOCOCCAL INFECTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NORWAY; PNEUMONIA; PRIORITY JOURNAL; SEROTYPING; SMEZ GENE; SSA GENE; STREPTOCOCCAL PYROGENIC EXOTOXIN; STREPTOCOCCUS PYOGENES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL TYPING TECHNIQUES; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; DNA FINGERPRINTING; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NORWAY; SEQUENCE ANALYSIS, DNA; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SUPERANTIGENS; VIRULENCE FACTORS; YOUNG ADULT;

STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A';

EID: 77749331784     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01312-09     Document Type: Article

References (59)

1. Abbot, E. L., W. D. Smith, G. P. S. Siou, C. Chiriboga, R. J. Smith, J. A. Wilson, B. H. Hirst, and M. A. Kehoe. 2007. Pili mediate specific adhesion of Streptococcus pyogenes to human tonsil and skin. Cell. Microbiol. 9:1822-1833.
2. Banks, D. J., S. B. Beres, and J. M. Musser. 2002. The fundamental contribution of phages to GAS evolution, genome diversification and strain emergence. Trends Microbiol. 10:515-521.
3. Beall, B., R. Facklam, and T. Thompson. 1996. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J. Clin. Microbiol. 34:953-958.
4. Beres, S. B., G. L. Sylva, K. D. Barbian, B. Lei, J. S. Hoff, N. D. Mammarella, M. Y. Liu, J. C. Smoot, S. F. Porcella, L. D. Parkins, D. S. Campbell, T. M. Smith, J. K. McCormick, D. Y. Leung, P. M. Schlievert, and J. M. Musser. 2002. Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc. Natl. Acad. Sci. USA 99:10078-10083.
5. Billal, D. S., D. P. Fedorko, S. S. Yan, M. Hotomi, K. Fujihara, N. Nelson, and N. Yamanaka. 2007. In vitro induction and selection of fluoroquinoloneresistant mutants of Streptococcus pyogenes strains with multiple emm types. J. Antimicrob. Chemother. 59:28-34.
6. Billal, D. S., M. Hotomi, S. S. Yan, D. P. Fedorko, J. Shimada, K. Fujihara, and N. Yamanaka. 2009. Loss of erythromycin resistance genes from strains of Streptococcus pyogenes that have developed resistance to levofloxacin. Diagn. Microbiol. Infect. Dis. 64:225-228.
7. Bisno, A. L., M. O. Brito, and C. M. Collins. 2003. Molecular basis of group A streptococcal virulence. Lancet Infect. Dis. 3:191-200.
8. Bisno, A. L., and D. L. Stevens. 1996. Streptococcal infections of skin and soft tissues. N. Engl. J. Med. 334:240-245.
9. Bucher, A., P. R. Martin, E. A. Høiby, A. Halstensen, A. ∅degaard, K. B. Hellum, L. Westlie, and S. Hallan. 1992. Spectrum of disease in bacteraemic patients during a Streptococcus pyogenes serotype M-1 epidemic in Norway in 1988. Eur. J. Clin. Microbiol. Infect. Dis. 11:416-426.
10. CLSI. 2009. Performance standards for antimicrobial susceptibility testing. Document M100-S19. CLSI, Wayne, PA.
11. Colman, G., A. Tanna, A. Efstratiou, and E. T. Gaworzewska. 1993. The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease. J. Med. Microbiol. 39:165-178.
12. Commons, R., S. Rogers, T. Gooding, M. Danchin, J. Carapetis, R. Robins-Browne, and N. Curtis. 2008. Superantigen genes in group A streptococcal isolates and their relationship with emm types. J. Med. Microbiol. 57:1238-1246.
13. Cunningham, M. W. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470-511.
14. Darenberg, J., B. Luca-Harari, A. Jasir, A. Sandgren, H. Pettersson, C. Schalén, M. Norgren, V. Romanus, A. Norrby-Teglund, and B. H. Normark. 2007. Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin. Infect. Dis. 45:450-458.
15. Efstratiou, A. 2000. Group A streptococci in the 1990s. J. Antimicrob. Chemother. 45(Suppl.):3-12.
16. Enright, M. C., B. G. Spratt, A. Kalia, J. H. Cross, and D. E. Bessen. 2001. Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone. Infect. Immun. 69:2416-2427.
17. Eriksson, B. K. G., M. Norgren, K. McGregor, B. G. Spratt, and B. H. Normark. 2003. Group A streptococcal infections in Sweden: a comparative study of invasive and noninvasive infections and analysis of dominant T28 emm28 isolates. Clin. Infect. Dis. 37:1189-1193.
18. Ferretti, J. J., W. M. McShan, D. Ajdic, D. J. Savic, G. Savic, K. Lyon, C. Primeaux, S. Sezate, A. N. Suvorov, S. Kenton, H. S. Lai, S. P. Lin, Y. Qian, H. G. Jia, F. Z. Najar, Q. Ren, H. Zhu, L. Song, J. White, X. Yuan, S. W. Clifton, B. A. Roe, and R. McLaughlin. 2001. Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc. Natl. Acad. Sci. USA 98:4658-4663.
19. Fraser, J. D., and T. Proft. 2008. The bacterial superantigen and superantigen-like proteins. Immunol. Rev. 225:226-243.
20. Green, N. M., S. Zhang, S. F. Porcella, M. J. Nagiec, K. D. Barbian, S. B. Beres, R. B. Lefebvre, and J. M. Musser. 2005. Genome sequence of a serotype M28 strain of group A streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity. J. Infect. Dis. 192:760-770.
21. Igwe, E. I., P. L. Shewmaker, R. R. Facklam, M. M. Farley, C. Van Beneden, and B. Beall. 2003. Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans. FEMS Microbiol. Lett. 229:259-264.
22. Ikebe, T., A. Wada, Y. Inagaki, K. Sugama, R. Suzuki, D. Tanaka, A. Tamaru, Y. Fujinaga, Y. Abe, Y. Shimizu, and H. Watanabe. 2002. Dissemination of the phage-associated novel superantigen gene speL in recent invasive and noninvasive Streptococcus pyogenes M3/T3 isolates in Japan. Infect. Immun. 70:3227-3233.
23. Jaggi, P., R. R. Tanz, B. Beall, and S. T. Shulman. 2005. Age influences the emm type distribution of pediatric group A streptococcal pharyngeal isolates. Pediatr. Infect. Dis. J. 24:1089-1092.
24. Johnson, D. R., E. L. Kaplan, A. VanGheem, R. R. Facklam, and B. Beall. 2006. Characterization of group A streptococci (Streptococcus pyogenes): correlation of M-protein and emm-gene type with T-protein agglutination pattern and serum opacity factor. J. Med. Microbiol. 55:157-164.
25. Keefer, C. S., F. J. Ingelfinger, and W. W. Spink. 1937. Significance of hemolytic streptococcic bacteremia: a study of two hundred and forty-six patients. Arch. Intern. Med. 50:1084-1097.
26. Lamagni, T. L., J. Darenberg, B. Luca-Harari, T. Siljander, A. Efstratiou, B. Henriques-Normark, J. Vuopio-Varkila, A. Bouvet, R. Creti, K. Ekelund, M. Koliou, R. R. Reinert, A. Stathi, L. Strakova, V. Ungureanu, C. Schalen, and A. Jasir. 2008. Epidemiology of severe Streptococcus pyogenes disease in Europe. J. Clin. Microbiol. 46:2359-2367.
27. Lamagni, T. L., S. Neal, C. Keshishian, N. Alhaddad, R. George, G. Duckworth, J. Vuopio-Varkila, and A. Efstratiou. 2008. Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004. Emerg. Infect. Dis. 14:202-209.
28. Lamagni, T. L., S. Neal, C. Keshishian, V. Hope, R. George, G. Duckworth, J. Vuopio-Varkila, and A. Efstratiou. 2008. Epidemic of severe Streptococcus pyogenes infections in injecting drug users in the UK, 2003-2004. Clin. Microbiol. Infect. 14:1002-1009.
29. Littauer, P., D. A. Caugant, M. Sangvik, E. A. Høiby, A. Sundsfjord, and G. S. Simonsen. 2006. Macrolide-resistant Streptococcus pyogenes in Norway: population structure and resistance determinants. Antimicrob. Agents Chemother. 50:1896-1899.
30. Luca-Harari, B., J. Darenberg, S. Neal, T. Siljander, L. Strakova, A. Tanna, R. Creti, K. Ekelund, M. Koliou, P. T. Tassios, M. van der Linden, M. Straut, J. Vuopio-Varkila, A. Bouvet, A. Efstratiou, C. Schalen, B. Henriques-Normark, and A. Jasir. 2009. Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J. Clin. Microbiol. 47:1155-1165.
31. Luca-Harari, B., K. Ekelund, M. van der Linden, M. Staum-Kaltoft, A. M. Hammerum, and A. Jasir. 2008. Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J. Clin. Microbiol. 46:79-86.
32. Manetti, A. G. O., C. Zingaretti, F. Falugi, S. Capo, M. Bombaci, F. Bagnoli, G. Gambellini, G. Bensi, M. Mora, A. M. Edwards, J. M. Musser, E. A. Graviss, J. L. Telford, G. Grandi, and I. Margarit. 2007. Streptococcus pyogenes pili promote pharyngeal cell adhesion and biofilm formation. Mol. Microbiol. 64:968-983.
33. Maripuu, L., A. Eriksson, and M. Norgren. 2008. Superantigen gene profile diversity among clinical group A streptococcal isolates. FEMS Immunol. Med. Microbiol. 54:236-244.
34. Martin, P. R., and E. A. Høiby. 1990. Streptococcal serogroup A epidemic in Norway 1987-1988. Scand. J. Infect. Dis. 22:421-429.
35. Maxted, W. R., J. P. Widdowson, C. A. Fraser, L. C. Ball, and D. C. J. Bassett. 1973. The use of the serum-opacity reaction in the typing of group-A streptococci. J. Med. Microbiol. 6:83-90.
36. McGregor, K. F., N. Bilek, A. Bennett, A. Kalia, B. Beall, J. R. Carapetis, B. J. Currie, K. S. Sriprakash, B. G. Spratt, and D. E. Bessen. 2004. Group A streptococci from a remote community have novel multilocus genotypes but share emm types and housekeeping alleles with isolates from worldwide sources. J. Infect. Dis. 189:717-723.
37. McGregor, K. F., B. G. Spratt, A. Kalia, A. Bennett, N. Bilek, B. Beall, and D. E. Bessen. 2004. Multilocus sequence typing of Streptococcus pyogenes representing most known emm types and distinctions among subpopulation genetic structures. J. Bacteriol. 186:4285-4294.
38. Meisal, R., E. A. Høiby, I. S. Aaberge, and D. A. Caugant. 2008. Sequence type and emm type diversity in Streptococcus pyogenes isolates causing invasive disease in Norway between 1988 and 2003. J. Clin. Microbiol. 46:2102-2105.
39. Michos, A. G., C. G. Bakoula, M. Braoudaki, F. I. Koutouzi, E. S. Roma, A. Pangalis, G. Nikolopoulou, E. Kirikou, and V. P. Syriopoulou. 2009. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types. Diagn. Microbiol. Infect. Dis. 64:295-299.
40. Moody, M. D., J. Padula, D. Lizana, and C. T. Hall. 1965. Epidemiologic characterization of group A streptococci by T-agglutination and M-precipitation tests in the public health laboratory. Health Lab. Sci. 2:149-162.
41. Mora, M., G. Bensi, S. Capo, F. Falugi, C. Zingaretti, A. G. O. Manetti, T. Maggi, A. R. Taddei, G. Grandi, and J. L. Telford. 2005. Group A Streptococcus produce pilus-like structures containing protective antigens and Lancefield T antigens. Proc. Natl. Acad. Sci. USA 102:15641-15646.
42. NORM/NORM-VET. 2006. Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway. Tromsø/Oslo 2007. National Veterinary Institute, Oslo, Norway.
43. NORM/NORM-VET. 2007. Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway. Tromsø/Oslo 2008. National Veterinary Institute, Oslo, Norway.
44. O'Loughlin, R. E., A. Roberson, P. R. Cieslak, R. Lynfield, K. Gershman, A. Craig, B. A. Albanese, M. M. Farley, N. L. Barrett, N. L. Spina, B. Beall, L. H. Harrison, A. Reingold, and C. Van Beneden. 2007. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin. Infect. Dis. 45:853-862.
45. Proft, T., and J. D. Fraser. 2003. Bacterial superantigens. Clin. Exp. Immunol. 133:299-306.
46. Proft, T., P. D. Webb, V. Handley, and J. D. Fraser. 2003. Two novel superantigens found in both group A and group C Streptococcus. Infect. Immun. 71:1361-1369.
47. Rivera, A., M. Rebollo, E. Miró, M. Mateo, F. Navarro, M. Gurguí, B. Mirelis, and P. Coll. 2006. Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain. J. Med. Microbiol. 55:1115-1123.
48. Sakota, V., A. M. Fry, T. M. Lietman, R. R. Facklam, Z. Li, and B. Beall. 2006. Genetically diverse group A streptococci from children in far-western Nepal share high genetic relatedness with isolates from other countries. J. Clin. Microbiol. 44:2160-2166.
49. Schmitz, F. J., A. Beyer, E. Charpentier, B. H. Normark, M. Schade, A. C. Fluit, D. Hafner, and R. Novak. 2003. Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates. J. Infect. Dis. 188:1578-1586.
50. Schwartz, B., R. R. Facklam, and R. F. Breiman. 1990. Changing epidemiology of group A streptococcal infection in the U.S.A. Lancet 336:1167-1171.
51. Siljander, T., O. Lyytikäinen, S. Vähäkuopus, P. Säilä, J. Jalava, and J. Vuopio-Varkila. 2009. Rapid emergence of emm84 among invasive Streptococcus pyogenes infections in Finland. J. Clin. Microbiol. 47:477-480.
52. Silva-Costa, C., F. R. Pinto, M. Ramirez, and J. Melo-Cristino. 2008. Decrease in macrolide resistance and clonal instability among Streptococcus pyogenes in Portugal. Clin. Microbiol. Infect. 14:1152-1159.
53. Smoot, J. C., K. D. Barbian, J. J. Van Gompel, L. M. Smoot, M. S. Chaussee, G. L. Sylva, D. E. Sturdevant, S. M. Ricklefs, S. F. Porcella, L. D. Parkins, S. B. Beres, D. S. Campbell, T. M. Smith, Q. Zhang, V. Kapur, J. A. Daly, L. G. Veasy, and J. M. Musser. 2002. Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc. Natl. Acad. Sci. USA 99:4668-4673.
54. Smoot, J. C., E. K. Korgenski, J. A. Daly, L. G. Veasy, and J. M. Musser. 2002. Molecular analysis of group A Streptococcus type emm18 isolates temporally associated with acute rheumatic fever outbreaks in Salt Lake City, Utah. J. Clin. Microbiol. 40:1805-1810.
55. Smoot, L. M., J. K. McCormick, J. C. Smoot, N. P. Hoe, I. Strickland, R. L. Cole, K. D. Barbian, C. A. Earhart, D. H. Ohlendorf, L. G. Veasy, H. R. Hill, D. Y. Leung, P. M. Schlievert, and J. M. Musser. 2002. Characterization of two novel pyrogenic toxin superantigens made by an acute rheumatic fever clone of Streptococcus pyogenes associated with multiple disease outbreaks. Infect. Immun. 70:7095-7104.
56. Sutcliffe, J., A. Tait-Kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824.
57. Tyler, S. D., W. M. Johnson, J. C. Huang, F. E. Ashton, G. Wang, D. E. Low, and K. R. Rozee. 1992. Streptococcal erythrogenic toxin genes: detection by polymerase chain reaction and association with disease in strains isolated in Canada from 1940 to 1991. J. Clin. Microbiol. 30:3127-3131.
58. Vlaminckx, B., W. van Pelt, L. Schouls, A. van Silfhout, C. Elzenaar, E. Mascini, J. Verhoef, and J. Schellekens. 2004. Epidemiological features of invasive and noninvasive group A streptococcal disease in the Netherlands, 1992-1996. Eur. J. Clin. Microbiol. Infect. Dis. 23:434-444.
59. Whatmore, A. M., and M. A. Kehoe. 1994. Horizontal gene transfer in the evolution of group A streptococcal emm-like genes: gene mosaics and variation in Vir regulons. Mol. Microbiol. 11:363-374.